Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (81-90 of 499) with videos related to

Pageof 50
Sort By:
Cancer Research|May 31, 2002
Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitroJi-Yao Sun, Robert S Krouse, Stephen J Forman, et al.
Leukemia Research|April 8, 2021
Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCTHaris Ali, Amandeep Salhotra, Anthony S Stein, et al.
Scientific Reports|November 27, 2023
Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myelomaDennis Awuah, Lin Li, Lindsay Williams, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 11, 2016
Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic LeukemiaMonzr M Al Malki, Ibrahim Aldoss, Tracey Stiller, et al.
Leukemia Research|June 25, 2017
Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemiaBijender Kumar, Arjun Kalvala, Su Chu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2015
Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationIbrahim Aldoss, Tracey Stiller, Thai M Cao, et al.
Blood|September 4, 2004
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatmentSu Chu, Helen Xu, Neil P Shah, et al.
Bone Marrow Transplantation|May 16, 2019
Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemiaIbrahim Aldoss, Ryotaro Nakamura, Dongyun Yang, et al.
American Journal of Hematology|February 1, 2021
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agentsTamer A Othman, Matthew Mei, Jianying Zhang, et al.
Leukemia & Lymphoma|August 22, 2012
Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemiaNeil Kogut, Ni-Chun Tsai, Sandra H Thomas, et al.
Pageof 50

Showing results (81-90 of 499) with videos related to

Sort By:
Pageof 50
Cancer Research|May 31, 2002
Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitroJi-Yao Sun, Robert S Krouse, Stephen J Forman, et al.
Leukemia Research|April 8, 2021
Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCTHaris Ali, Amandeep Salhotra, Anthony S Stein, et al.
Scientific Reports|November 27, 2023
Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myelomaDennis Awuah, Lin Li, Lindsay Williams, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 11, 2016
Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic LeukemiaMonzr M Al Malki, Ibrahim Aldoss, Tracey Stiller, et al.
Leukemia Research|June 25, 2017
Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemiaBijender Kumar, Arjun Kalvala, Su Chu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2015
Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationIbrahim Aldoss, Tracey Stiller, Thai M Cao, et al.
Blood|September 4, 2004
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatmentSu Chu, Helen Xu, Neil P Shah, et al.
Bone Marrow Transplantation|May 16, 2019
Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemiaIbrahim Aldoss, Ryotaro Nakamura, Dongyun Yang, et al.
American Journal of Hematology|February 1, 2021
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agentsTamer A Othman, Matthew Mei, Jianying Zhang, et al.
Leukemia & Lymphoma|August 22, 2012
Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemiaNeil Kogut, Ni-Chun Tsai, Sandra H Thomas, et al.
Pageof 50